__timestamp | BioMarin Pharmaceutical Inc. | GSK plc |
---|---|---|
Wednesday, January 1, 2014 | 129764000 | 7323000000 |
Thursday, January 1, 2015 | 152008000 | 8853000000 |
Friday, January 1, 2016 | 209620000 | 9290000000 |
Sunday, January 1, 2017 | 241786000 | 10342000000 |
Monday, January 1, 2018 | 315264000 | 10241000000 |
Tuesday, January 1, 2019 | 359466000 | 11863000000 |
Wednesday, January 1, 2020 | 524272000 | 11704000000 |
Friday, January 1, 2021 | 470515000 | 11603000000 |
Saturday, January 1, 2022 | 483669000 | 9554000000 |
Sunday, January 1, 2023 | 577065000 | 8565000000 |
Monday, January 1, 2024 | 580235000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for GSK plc and BioMarin Pharmaceutical Inc. from 2014 to 2023. Over this period, GSK plc consistently reported a higher cost of revenue, peaking in 2019 with a 62% increase from 2014. In contrast, BioMarin Pharmaceutical Inc. showed a more dynamic growth, with a staggering 345% rise in cost of revenue by 2023. This trend reflects BioMarin's aggressive expansion and investment in research and development. Meanwhile, GSK's cost fluctuations suggest strategic shifts in its operational focus. As the pharmaceutical landscape continues to change, these insights provide a window into the financial strategies of two industry giants.
Cost of Revenue Trends: Merck & Co., Inc. vs BioMarin Pharmaceutical Inc.
Cost of Revenue Comparison: Pfizer Inc. vs BioMarin Pharmaceutical Inc.
Cost Insights: Breaking Down Gilead Sciences, Inc. and GSK plc's Expenses
Cost Insights: Breaking Down GSK plc and Insmed Incorporated's Expenses
Cost of Revenue Comparison: GSK plc vs Walgreens Boots Alliance, Inc.
GSK plc vs Jazz Pharmaceuticals plc: Efficiency in Cost of Revenue Explored
Analyzing R&D Budgets: GSK plc vs BioMarin Pharmaceutical Inc.
Comparing Cost of Revenue Efficiency: GSK plc vs Veracyte, Inc.
GSK plc vs MiMedx Group, Inc.: Efficiency in Cost of Revenue Explored
United Therapeutics Corporation vs BioMarin Pharmaceutical Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: BioMarin Pharmaceutical Inc. vs Sarepta Therapeutics, Inc.
Cost of Revenue Trends: BioMarin Pharmaceutical Inc. vs Cytokinetics, Incorporated